Top Markets
Coin of the day
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.

TARO
Kedudukan dalam Saham #7345
Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven... Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven pharmaceutical enterprise, specializing in the development, manufacturing, and commercialization of both prescription and over-the-counter medications. Its market reach spans the United States, Canada, Israel, and various other international territories. The company also produces active pharmaceutical ingredients (APIs), primarily for integration into its own finished dosage form products. Its extensive product catalog addresses a broad spectrum of medical conditions and therapeutic areas, encompassing treatments for allergies, pain (analgesic), bacterial and fungal infections (antibacterial, antibiotic, antifungal), seizures (anticonvulsant), nausea (antiemetic), inflammation (anti-inflammatory), cancer (anti-cancer, topical anti-neoplastic), blood clot prevention (antiplatelet agent), fever reduction (antipyretic), cardiovascular issues, central nervous system disorders, hormonal regulation (corticosteroid, endocrine), cosmetic applications, coughs and colds, dermatological complaints, fluid management (diuretic), gastrointestinal problems, constipation (laxative), severe pain (narcotics), neuropathic pain, neuropsychiatric conditions, and sleep/anxiety management (sedative/hypnotic). These pharmaceutical goods are available in numerous formats, including capsules, creams, drops, emulsions, gels (and gel kits), granules, injectables, lotions, oils, ointments, pastes, powders (and powders for solution), rectal suppositories, shampoos, solutions (and solutions for infusion), sprays, suspensions, syrups, tablets, toothpastes and mouthwashes, topical foams, and topical solutions. Taro distributes and sells its products directly to a wide array of clients, such as pharmaceutical wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, other direct purchasers, and various healthcare institutions and private pharmacies. The company was established in 1950, with its main offices situated in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a wholly-owned subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
Harga Saham
$42.98
Disegerakkan terakhir: 2024-06-21
Modal Pasaran
$1.62B
Perubahan (1 hari)
0.01%
Perubahan (1 tahun)
0.00%
Negara
IL
Perdagangan Taro Pharmaceutical Industries Ltd. (TARO)

Kategori

Pendapatan untuk Taro Pharmaceutical Industries Ltd. (TARO)
Pendapatan pada Mar 2024 TTM: $82.67M
Menurut laporan kewangan terkini Taro Pharmaceutical Industries Ltd., pendapatan semasa syarikat ialah $82.67M. Pada tahun 2023, syarikat memperoleh pendapatan sebanyak $38.21M, penurunan berbanding pendapatan pada tahun 2022 yang berjumlah $77.86M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Taro Pharmaceutical Industries Ltd. dari 1999 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
2026 (TTM) $82.67M 0.00%
2024 $82.67M 116.33%
2023 $38.21M -50.92%
2022 $77.86M -119.91%
2021 $-391.07M -231.35%
2020 $297.73M -16.57%
2019 $356.85M 22.06%
2018 $292.37M -47.87%
2017 $560.80M -11.94%
2016 $636.82M 9.48%
2015 $581.68M 31.04%
2014 $443.91M 32.17%
2013 $335.86M 39.40%
2012 $240.93M 219.63%
2010 $75.38M 60.06%
2009 $47.09M 6.88%
2008 $44.06M 8.67%
2007 $40.55M -149.57%
2006 $-81.81M -1,221.57%
2005 $7.29M -205.21%
2004 $-6.93M -109.50%
2003 $72.96M 37.75%
2002 $52.96M 74.37%
2001 $30.37M 141.72%
2000 $12.57M 79.24%
1999 $7.01M 0.00%
Pendapatan untuk syarikat atau pesaing serupa